Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "KEYLYNK-009 Study - Pembro + Olaparib vs. Pembro + Chemo After Induction With Pembro + Chemo for Locally Recurrent Inoperable or Metastatic TNBC"
By
Insights from 2023 SABCS
FEATURING
Hope Rugo
By
Insights from 2023 SABCS
FEATURING
Hope Rugo
321 views
December 15, 2023
Comments 0
Login to view comments.
Click here to Login
Videos